Inventor · disambiguated record
James Cregg
Also filed as: CREGG JAMES · CREGG JAMES JOSEPH
18 granted patents·20 pending applications·67 citations·filing 2019–2025
93Inventor score
Files withREVOLUTION MEDICINES INC38
Top patents by PatentIndex Score
38 records- 0198US12465643B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Granted Nov 11, 2025·1 cites·2 claims
- 0298US11952352B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Apr 9, 2024·6 cites·4 claims
- 0398US11608346B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Mar 21, 2023·9 cites·7 claims
- 0497US11566007B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jan 31, 2023·10 cites·2 claims
- 0596US12280113B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Apr 22, 2025·2 cites·4 claims
- 0696US11739074B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Aug 29, 2023·9 cites·2 claims
- 0795US12202845B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Jan 21, 2025·3 cites·6 claims
- 0895US11685749B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 27, 2023·5 cites·8 claims
- 0994US12252497B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 18, 2025·3 cites·10 claims
- 1094US12187746B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jan 7, 2025·5 cites·9 claims
- 1194US11690915B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2021·Granted Jul 4, 2023·9 cites·2 claims
- 1294US11168102B1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Granted Nov 9, 2021·5 cites·18 claims
- 1390US2025388608A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 1488US2025145643A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1586US12384750B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Granted Aug 12, 2025·0 cites·8 claims
- 1682US12409225B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Granted Sep 9, 2025·0 cites·23 claims
- 1782US12403196B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Granted Sep 2, 2025·0 cites·4 claims
- 1880US2025255964A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 1980US2025319187A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 2079US2023106174A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 2176US2025074923A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 2276US2025361245A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 2375US2025051306A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 2475US2023374035A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2573US12258366B2Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 2670US2024067636A1Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2770US2024101577A1Polycyclic compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2869US2025368661A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 2968US2019336609A1C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR InhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 3067US2025197423A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3167US2025154171A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3266US11702411B2Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jul 18, 2023·0 cites·6 claims
- 3364US2021139517A1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
- 3461US2025388598A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 3561US2025129097A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3660US11673901B2Polycyclic compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 13, 2023·0 cites·19 claims
- 3748US2023096028A1Bicyclic heterocyclyl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
- 3847US2023148450A9Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Cregg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →